International Journal of Pharmaceutical Compounding

A subscription to IJPC provides on-line access to full-text, full-color, printable PDF copies of your subscribed issues, individual articles, and purchased archives.

LEARN MORE

Sterile Basics: Intravenous Admixture Preparation Considerations, Part 4: Particulates

Author(s): Allen Loyd V Jr

Issue: May/Jun 2020 - Volume 24, Number 3
View All Articles in Issue

Page(s): 215-220

Sterile Basics: Intravenous Admixture Preparation Considerations, Part 4: Particulates Page 1

Sterile Basics: Intravenous Admixture Preparation Considerations, Part 4: Particulates Page 2

Sterile Basics: Intravenous Admixture Preparation Considerations, Part 4: Particulates Page 3

Sterile Basics: Intravenous Admixture Preparation Considerations, Part 4: Particulates Page 4

Sterile Basics: Intravenous Admixture Preparation Considerations, Part 4: Particulates Page 5

Sterile Basics: Intravenous Admixture Preparation Considerations, Part 4: Particulates Page 6

Download in electronic PDF format for $75

Abstract: Intravenous admixture compounding requires knowledge of stability, compatibility, and incompatibility issues related to the complete composition and formulation. In evaluating an intravenous admixture, one is not just concerned with the active ingredients but also with all the excipients. Both active pharmaceutical ingredients and excipients used in the formulations of commercially available products may vary among manufacturers and can influence drug compatibility and stability. Clinical pharmaceutics includes the study and application of pharmaceutics to clinical compounding situations to aid in the evaluation of each intravenous admixture. A critical aspect of successful intravenous admixture preparation is the prevention or minimization of particulate matter in the finished product. This article discusses the source, method of prevention, and detection of particulates in intravenous admixtures.

Related Keywords: Loyd V. Allen, Jr, PhD, RPh, parenteral preparations, drug admixtures, intravenous administration, compounded sterile preparations, particulate sources, adverse reactions, visual inspection, compounding standards, United States Pharmacopeia, USP, filtration

Related Categories: PARENTERALS, STABILITIES, COMPATIBILITIES, STERILE PREPARATIONS, QUALITY CONTROL

Printer-Friendly Version

Title/Author (Click for Abstract / Details / Purchase)	Issue/Page View/Buy
Related Articles from IJPC
Sterile Basics: Intravenous Admixture Preparation Considerations, Part 4: Particulates Allen Loyd V Jr	May/Jun 2020 Pg. 215-220
Intravenous Admixture Preparation Considerations, Part 9-A: Error Prevention in Intravenous Admixture Preparation Allen Loyd V Jr	Mar/Apr 2021 Pg. 131-139
Sterile Basics of Compounding: Particulates in Parenteral Preparations: Sources, Minimization, and Detection Allen Loyd V Jr	May/Jun 2022 Pg. 219-228
Intravenous Admixture Preparation Considerations, Part 9-B: Error Prevention in Intravenous Admixture Preparation Allen Loyd V Jr	May/Jun 2021 Pg. 222-229
Sterile Basics: Intravenous Admixture Preparation Considerations, Part 5: pH Considerations Allen Loyd V Jr	Jul/Aug 2020 Pg. 305-309
Basics of Sterile Compounding: Sterile Basics of Compounding Intravenous Admixtures, Part 4: Physicochemical Considerations Allen Loyd V Jr	Sep/Oct 2023 Pg. 397-409
Sterile Basics of Compounding: Intravenous Admixture Compounding, Part 3: Preparation Procedures Allen Loyd V Jr	Jul/Aug 2023 Pg. 305-313
Basics of Sterile Compounding: Intravenous Admixture Preparation, Part 11: Particulate Issues --- Silicone Oil in Vials, Cartridges, and Syringes Allen Loyd V Jr	Sep/Oct 2021 Pg. 403-408
Intravenous Admixture Preparation Considerations, Part 8: Ready-to-Use Preparations Allen Loyd V Jr	Jan/Feb 2021 Pg. 31-38
Basics of Sterile Compounding: Intravenous Admixture Preparation Considerations, Part 10: Packaging and Container-closure Issues Allen Loyd V Jr	Jul/Aug 2021 Pg. 311-317
Intravenous Admixture Preparation Considerations, Part 1: Overview of Series on Personnel Selection for Intravenous Admixture Compounding Allen Loyd V Jr	Nov/Dec 2019 Pg. 478-482
Sterile Basics: Intravenous Admixture Compounding, Part 2: Parenteral Vehicle Considerations Allen Loyd V Jr	May/Jun 2023 Pg. 223-229
Intravenous Admixture Preparation Considerations, Part 2: Incompatibilities and Factors Involved Allen Loyd V Jr	Jan/Feb 2020 Pg. 44-50
Basics of Sterile Compounding: Intravenous Admixture Preparation, Part 12: United States Pharmacopeia Chapters Referenced in the Current United States Pharmacopeia Chapter <797> Pharmaceutical Compounding -- Sterile Preparations Allen Loyd V Jr	Nov/Dec 2021 Pg. 491-496
Sterile Basics: Intravenous Admixture Compounding, Part 1: Introduction and Overview of the General Guidelines for an Intravenous Admixture Compounding Program, and Compounding Personnel Considerations Allen Loyd V Jr	Mar/Apr 2023 Pg. 123-139
Intravenous Admixture Preparation Considerations, Part 6: pH Considerations -- Applications Allen Loyd V Jr	Sep/Oct 2020 Pg. 397-402
Intravenous Admixture Preparation Considerations, Part 7: Stability Issues Allen Loyd V Jr	Nov/Dec 2020 Pg. 473-478
Basics of Sterile Compounding: Particulate Matter Akers Michael J	Sep/Oct 2017 Pg. 395-404
Compounding Enclosures: Ensuring Safety During the Preparation of Sterile and Nonsterile Formulations Ashe Krystina, Baskett Dustin	Sep/Oct 2018 Pg. 387-398
Intravenous Admixture Preparation Considerations, Part 3: Methods and Techniques to Decrease Incompatibilities Allen Loyd V Jr	Mar/Apr 2020 Pg. 121-126
Return to Top